These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38904026)

  • 1. m
    Long Y; Song D; Xiao L; Xiang Y; Li D; Sun X; Hong X; Hou FF; Fu H; Liu Y
    Int J Biol Sci; 2024; 20(8):3185-3200. PubMed ID: 38904026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 2 mRNA-binding protein 3 promotes kidney injury by regulating β-catenin signaling.
    Song D; Shang J; Long Y; Zhong M; Li L; Chen J; Xiang Y; Tan H; Zhu H; Hong X; Hou FF; Fu H; Liu Y
    JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36520532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis.
    Tsai YC; Hsieh TH; Liao YR; Tsai MT; Lin TP; Lee DY; Park J; Kim D; Susztak K; Yang SF; Lin CC; Li SY
    J Am Soc Nephrol; 2024 Oct; 35(10):1312-1329. PubMed ID: 39352860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the m
    Jung HR; Lee J; Hong SP; Shin N; Cho A; Shin DJ; Choi JW; Kim JI; Lee JP; Cho SY
    Exp Mol Med; 2024 Feb; 56(2):355-369. PubMed ID: 38297163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyltransferase-Like 3-Mediated N6-Methyladenosine RNA Methylation Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN.
    Jiang Y; Liu H; Shi R; Hao Y; Zhang J; Xin W; Li Y; Ma C; Zheng X; Zhang L; Zhao X; Zhu D
    J Am Heart Assoc; 2024 Oct; 13(19):e034470. PubMed ID: 39344585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LONP1 alleviates ageing-related renal fibrosis by maintaining mitochondrial homeostasis.
    Zhang C; Shen S; Xu L; Li M; Tian B; Yao L; Zhu X
    J Cell Mol Med; 2024 Sep; 28(17):e70090. PubMed ID: 39261902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-m6A methylation inhibits the proliferation and viability of type II alveolar epithelial cells in acute lung injury by enhancing the stability and translation efficiency of Pten mRNA.
    Wang Q; Shen J; Luo S; Yuan Z; Wei S; Li Q; Yang Q; Luo Y; Zhuang L
    Respir Res; 2024 Jul; 25(1):276. PubMed ID: 39010105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA AI662270 promotes kidney fibrosis through enhancing METTL3-mediated m
    Sun Y; Ge J; Shao F; Ren Z; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
    FASEB J; 2023 Aug; 37(8):e23071. PubMed ID: 37389924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3/N6-methyladenosine/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation.
    Liu E; Lv L; Zhan Y; Ma Y; Feng J; He Y; Wen Y; Zhang Y; Pu Q; Ji F; Yang X; Wen JG
    J Cell Mol Med; 2021 Aug; 25(16):7660-7674. PubMed ID: 34164910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
    Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
    Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA N
    Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
    Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease.
    Nlandu-Khodo S; Osaki Y; Scarfe L; Yang H; Phillips-Mignemi M; Tonello J; Saito-Diaz K; Neelisetty S; Ivanova A; Huffstater T; McMahon R; Taketo MM; deCaestecker M; Kasinath B; Harris RC; Lee E; Gewin LS
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32369448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.